Skip to main content
Equibles

BlackRock, Inc.

Position in AKTS — Aktis Oncology, Inc.

CIK 2012383 New York, NY
Back to AKTS Full portfolio

Position in AKTS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$73,431,474
+$35,645,526 QoQ
Shares Held
2,278,358
+7.9% QoQ
Ownership
4.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in AKTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,603,777,939 across 474 Biotechnology names. AKTS ranks #142 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 24,109,373 $11,975,848,839
2 REGN
Regeneron Pharmaceuticals, Inc.
 9,113,506 $5,682,635,520
3 ALNY
Alnylam Pharmaceuticals, Inc.
 10,907,675 $3,283,537,392
4 RVMD
Revolution Medicines, Inc.
 13,695,790 $2,564,947,540
5 MRNA
Moderna, Inc.
 30,599,409 $2,142,876,602
6 INCY
Incyte Corp
 18,032,718 $2,044,188,902
7 CYTK
Cytokinetics Inc
 20,094,362 $1,711,838,691
8 ROIV
Roivant Sciences Ltd.
 48,236,091 $1,707,075,250

All Filings in AKTS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $73,431,474 2,278,358
2026-03-31 $37,785,948 2,112,127